💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
User | Tweets |
---|---|
@askwarrenbuffet | 3 |
@biotechradar_eu | 2 |
@Franca_ole | 2 |
@lblegend33 | 1 |
@redacre | 1 |
![]() |
@lblegend33 @redacre $immu? Didn’t that get BO while back? April 14th 2021, 8:04pm |
![]() |
@Franca_ole FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial #cancer #Trodelvy $IMMU $GILD https://t.co/sf5MnkCPeP April 14th 2021, 9:04am |
![]() |
@biotechradar_eu Immunicum $IMMU Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai https://t.co/zvuXJGkhwA April 14th 2021, 8:04am |
![]() |
@jq1234t @bigpharmaguy Don’t think that’s the right comparison. $IMMU FDA AA approval great but bigger driver was huge succe… https://t.co/yxriRtxLp0 April 9th 2021, 4:04pm |
![]() |
@JosephRamelli RT @bigpharmaguy: Probably an unpopular take but $FGEN here gives me shades of $IMMU a year ago. Both had separate issues and were in revie… April 9th 2021, 2:04pm |
![]() |
@bigpharmaguy Probably an unpopular take but $FGEN here gives me shades of $IMMU a year ago. Both had separate issues and were in… https://t.co/5wFFhIZZSS April 9th 2021, 1:04pm |
![]() |
@Franca_ole #FDA grants regular approval to #sacituzumab govitecan for triple-negative breast cancer https://t.co/OWnOVz2XdZ $IMMU $CYDY #TNBC April 7th 2021, 10:04pm |
![]() |
@biotechradar_eu Immunicum $IMMU Announces Investor Event and Conference Participation for April https://t.co/PAlAhew3ih April 7th 2021, 9:04am |
![]() |
@askwarrenbuffet $HMBL CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/a4PRNFbtdS April 6th 2021, 8:04pm |
![]() |
@redacre Biotech/HC New or revisited 52-Week Lows: $ACAD $IMMU April 6th 2021, 8:04pm |
![]() |
@stockmarkettile @LemonyS14621590 @Discover_Divs And their acquisition of $IMMU, how’s that going? April 5th 2021, 11:04pm |
![]() |
@askwarrenbuffet $CSOC CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/zPffnBiSQL April 3rd 2021, 7:04pm |
![]() |
@MimedxGroupie A threat for $IMMU said the paid $CYDY moron. https://t.co/qeiOXRvOVc https://t.co/eN6Lox6LPP April 2nd 2021, 9:04am |
![]() |
@askwarrenbuffet $CSOC CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/njguYyveX0 April 1st 2021, 4:04am |
![]() |
@redacre Biotech/HC New or revisited 52-Week Lows: $GEN $IMMU March 31st 2021, 8:03pm |
![]() |
@askwarrenbuffet $ATMH CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/61h3KPi3P5 March 28th 2021, 2:03am |
![]() |
@haodongvli $XBI you have to go shopping when people think it is a landfill, as a matter of fact, it is a gold mine! $IMMU… https://t.co/gkMTk8aQbO March 26th 2021, 4:03pm |
![]() |
@DesertDweller93 Hard to believe $sgen market cap getting close to where $immu was bought out at. sgen with its approved drugs plus… https://t.co/BhMk3kr7AG March 24th 2021, 4:03pm |
![]() |
@askwarrenbuffet $COG CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/sx0YIgY535 March 22nd 2021, 11:03pm |
![]() |
@askwarrenbuffet $LEAS CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/HT5YVgyQlt March 19th 2021, 5:03am |
![]() |
@askwarrenbuffet $RXMD CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/nZWeGN7Gc7 March 18th 2021, 2:03am |
![]() |
@eyemightbewrong @LSValue I actually looked at $immu with Shkreli traded emails in prison ha and he and I were both like how is this… https://t.co/9BO1oiZLV8 March 17th 2021, 6:03am |
![]() |
@MayWatchTooMuch @TheLioncom OK, I am in too. Always looking for my next $IMMU March 16th 2021, 5:03am |
![]() |
@askwarrenbuffet $CRM CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/YCM2fzNm9L March 16th 2021, 3:03am |
![]() |
@askwarrenbuffet $CLSK CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/aDbTNrJso6 March 13th 2021, 3:03am |
![]() |
@Panacea_Trading $ACAD shades of $IMMU? Or is this something more.. March 9th 2021, 2:03pm |
![]() |
@hcgeneralist I remember when $IMMU got a CRL for manufacturing reasons. A while later I talked with a person that knew them well… https://t.co/whAxRIlhvc March 9th 2021, 12:03pm |
![]() |
@sbwcws UBS pharmaceuticals analysts to hold an analyst/industry conference call $AZN $IMMU March 8th 2021, 4:03pm |
![]() |
@askwarrenbuffet $HQGE CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/cVVcVslasl March 4th 2021, 1:03am |
![]() |
@biotechradar_eu Immunicum $IMMU Announces Appointment of Jeroen Rovers as Chief Medical Officer https://t.co/xKKHlLdHgi March 1st 2021, 7:03am |
![]() |
@askwarrenbuffet $CBDD CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/2DnFi6444p February 26th 2021, 5:02am |
![]() |
@askwarrenbuffet $NPHC CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/3ujgTRrTUZ February 25th 2021, 2:02am |
![]() |
@biotechradar_eu Immunicum $IMMU Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney C… https://t.co/ZKDrT2azOS February 22nd 2021, 8:02am |
![]() |
@biotechradar_eu Immunicum $IMMU Receives Orphan Drug Designation from EMA for Ilixadencel as Treatment for Gastrointestinal Stromal… https://t.co/cp3WBqDziZ February 19th 2021, 7:02am |
![]() |
@askwarrenbuffet $PVDG CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/eW0ylwZpdC February 19th 2021, 2:02am |
![]() |
@biotechradar_eu Immunicum $IMMU Announces Year-End Results 2020 https://t.co/pwroL38jI9 February 18th 2021, 10:02am |
![]() |
@PaulTorresCohen Paul Torres-Cohen $IMMU February 15th 2021, 2:02pm |
![]() |
@BurchetJohn @austinfrank Lol. Like early 2020 when GS put a PT on $IMMU at $5.30. My little stake of 70k shares were settled Oc… https://t.co/kzUlZqVzpx February 14th 2021, 12:02pm |
![]() |
@Traderofstocks1 $IMMU https://t.co/ht1eyRUYPn February 12th 2021, 7:02pm |
![]() |
@askwarrenbuffet $TGODF CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/3d1aINYMYT February 12th 2021, 1:02am |
![]() |
@sunrgu @Sanctuary_Bio Only the best deal they ever made in recent years is $IMMU February 10th 2021, 2:02pm |
![]() |
@trademarktrader TRODELVY is under file for trademark by IMMUNOMEDICS, INC. https://t.co/C0jEDoveSP #TRODELVY $IMMU https://t.co/AqqzAyxSGk February 10th 2021, 1:02pm |
![]() |
@TimCarmichael3 $TGTX this situation mirrors what I witnessed with $IMMU —shepherd your drugs through the FDA, build up the sales f… https://t.co/DOvSQsoWfG February 5th 2021, 8:02pm |
![]() |
@YGOUCHA @Biohazard3737 And $IMMU prior February 5th 2021, 7:02pm |
![]() |
@Sanctuary_Bio RT @adar170: $IMMU Trodelvy 49 million https://t.co/RoIZQUm9B8 February 4th 2021, 9:02pm |
![]() |
@sunrgu $GILD $IMMU Trodelvy® (sacituzumab govitecan-hziy 180 mg) sales for the fourth quarter and full year 2020, includi… https://t.co/cFipMhdaBs February 4th 2021, 9:02pm |
![]() |
@adar170 $IMMU Trodelvy 49 million https://t.co/RoIZQUm9B8 February 4th 2021, 9:02pm |
![]() |
@MSS1992BIO @JacobPlieth Should have bought $immu when they had the chance February 4th 2021, 9:02am |
![]() |
@askwarrenbuffet $TXHE CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/zyzEAWHmXa February 4th 2021, 1:02am |
![]() |
@askwarrenbuffet $APYP CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/Oyd8FrKPCK February 2nd 2021, 1:02am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.